from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2271/-

LFCtreatmentdescriptionclass of inhibitor

0.010

Amikacinug/mL Amikacintranslation

0.646

Cap5-10ug/mL Capreomycintranslation

-0.206

Rox10-50 ug/mL Roxithromycintranslation

0.582

SM2-5 ug/mL Streptomycintranslation

-0.371

Tet5-10 ug/mL Tetracyclinetranslation

-0.266

Rif0.2-5ug/mL Rifampicintranscription

-0.653

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.033

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.407

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.795

CPZ10-50 ug/mL Chlorpromazinerespiration

0.031

Clofazimine10-13 ug/mL Clofaziminerespiration

0.923

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.479

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.518

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.287

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.914

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.430

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.314

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.374

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.069

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.418

KCN5-20 ug/mL Potassium cyaniderespiration

0.225

NaN30.2-2 mM Sodium aziderespiration

1.138

Nigericin50 uM Nigericinrespiration

-1.461

TRC10-150 ug/mL Triclosanrespiration

-1.657

TRZ10-25 ug/mL Thioridazinerespiration

-0.930

Valinomycin0.5-10 uM Valinomycinrespiration

1.579

ZnSO42 mM ZnSO4respiration

0.446

menadione6-10 ug/mL Menadionerespiration

-0.240

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.845

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.654

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.062

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.294

NRP_1Non-replicating persistence stage 1dosRassociated

0.846

Amp0.2mg/mL AmpicillincellWall

0.563

Cephalexin20-100 ug/mL CephalexincellWall

0.888

Cerulenin0.32-5 ug/mL CerulenincellWall

0.880

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.550

EMB10-20 ug/mL EthambutolcellWall

0.496

Eta12-40 ug/mL EthionamidecellWall

-0.026

INH0.2-0.4 ug/mL IsoniazidcellWall

0.614

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.895

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.071

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.143

BZA0.12 mg/mL BenzamidearomaticAmides

-0.341

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.315

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.411

H2O24 mM hydrogen peroxideDNAdamaging

0.068

Levo10 ug/mL LevofloxacinDNAdamaging

0.945

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.748

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.917

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.466

UVUV-irradiationDNAdamaging

-1.182

ARP41-4 ug/mL Antitubercular compound ARP4?

0.447

Antimycin12.5-50 ug/mL Antimycin A?

0.800

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.674

PA_110-50 ug/mL Antitubercular compound PA-1?

0.959

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.164

PA8240.2-2 ug/mL PA-824?

-1.298

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.022

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.512

Verapamil50 uM Verapamil?

1.056

mercaptoethanol2 mM 2-Mercaptoethanol?

0.799

methoxatin10-20 ug/mL Methoxatin?